Oxaliplatin

From WikiMD's Wellness Encyclopedia

(Redirected from Foloxatine)

What is Oxaliplatin?[edit | edit source]


Oxaliplatin
Oxaliplatin 3D ball



What are the uses of this medicine?[edit | edit source]

Oxaliplatin Injection (Eloxatin) is an anti-cancer (chemotherapy) medicine that is used with other anti-cancer medicines called fluorouracil and leucovorin to treat people with:


How does this medicine work?[edit | edit source]

  • Oxaliplatin (ox al" i pla' tin) is a cisplatin analog with a tetravalent platinum molecule which is referred to as a platinum coordination complex.
  • Oxaliplatin acts as an alkylating agent causing cross linking between and within DNA strands leading to inhibition of DNA, RNA and protein synthesis and the triggering of programmed cell death, mostly in rapidly dividing cells.


Who Should Not Use this medicine ?[edit | edit source]

This medicine cannot be used in patients who:

  • are allergic to any of the ingredients in Oxaliplatin Injection or other medicines that contain platinum.


What drug interactions can this medicine cause?[edit | edit source]

  • Tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take.
  • Be sure to mention oral anticoagulants ('blood thinners') such as warfarin (Coumadin).


Is this medicine FDA approved?[edit | edit source]

  • Oxaliplatin was patented in 1976 and approved for medical use in 1996.


How should this medicine be used?[edit | edit source]

Recommended dosage:

  • Administer Oxaliplatin Injection in combination with fluorouracil/leucovorin every 2 weeks.

Day 1:

  • Oxaliplatin Injection 85 mg/m2 intravenous infusion and leucovorin will be given through a thin plastic tube into a vein (intravenous infusion or IV) and given for 2 hours.
  • You will be watched by a healthcare provider during this time.
  • Right after the Oxaliplatin Injection and leucovorin are given, 2 doses of fluorouracil will be given.
  • The first dose is given right away into your IV tube.
  • The second dose will be given into your IV tube over the next 22 hours, using a pump device.

Day 2:

  • Leucovorin 200 mg/m2 intravenous infusion over 120 minutes, followed by fluorouracil 400 mg/m2 intravenous bolus given over 2 to 4 minutes, followed by fluorouracil 600 mg/m2 intravenous infusion in 500 mL 5% Dextrose Injection (recommended) as a 22-hour continuous infusion.
  • Reduce the dose of Oxaliplatin Injection to 75 mg/m2 (adjuvant setting) or 65 mg/m2 (advanced colorectal cancer).
  • For patients with severe renal impairment (creatinine clearance < 30 mL/min), the initial recommended dose is 65 mg/m².
  • Discontinue Oxaliplatin Injection if there are persistent Grade 3 neurosensory events.

Administration:

  • Oxaliplatin comes as a solution (liquid) to be injected into a vein.
  • Oxaliplatin is administered by a doctor or nurse.
  • It is usually given once every fourteen days.


What are the dosage forms and brand names of this medicine?[edit | edit source]

This medicine is available in fallowing doasage form:

  • As Injection: 50 mg/10 mL and 100 mg/20 mL in single-dose vials.

This medicine is available in fallowing brand namesː

  • Eloxatin


What side effects can this medication cause?[edit | edit source]

The most common side effects of this medicine include:

  • Numbness, pain, tingling, and/or burning along the nerves
  • Low white blood cells (neutropenia)
  • Low platelet count (important for clotting and to control bleeding)
  • Low red blood cells (blood cells that carry oxygen to the tissues)
  • Nausea
  • Changes in liver function tests
  • Diarrhea
  • Vomiting
  • Tiredness
  • Mouth sores

Oxaliplatin Injection can cause serious side effects, including:


What special precautions should I follow?[edit | edit source]

  • Grade 3/4 hypersensitivity, including anaphylactic/anaphylactoid reactions, to oxaliplatin has been observed in cancer patients. Monitor for development of rash, urticaria, erythema, pruritus, bronchospasm, and hypotension.
  • Oxaliplatin is associated with two types of neuropathy. Reduce the dose or discontinue Oxaliplatin Injection if necessary.
  • Grade 3 or 4 neutropenia occurred in 41 to 44% of patients with colorectal cancer treated with oxaliplatin in combination with flurouracil (FU) and leucovorin compared to 5% with FU plus leucovorin alone. Delay Oxaliplatin Injection until neutrophils are ≥1.5 x 109/L. Withhold Oxaliplatin Injection for sepsis.
  • Oxaliplatin has been associated with pulmonary fibrosis, which may be fatal. May need to discontinue Oxaliplatin Injection until interstitial lung disease or pulmonary fibrosis are excluded.
  • Hepatotoxicity as evidenced in the adjuvant study by increase in transaminases and alkaline phosphatase was observed. Monitor liver function tests.
  • QT prolongation and ventricular arrhythmias including fatal Torsade de Pointes have been reported in postmarketing experiences following oxaliplatin administration. Correct hypokalemia or hypomagnesemia prior to initiating Oxaliplatin Injection.
  • Rhabdomyolysis, including fatal cases, has been reported in patients treated with oxaliplatin. Discontinue Oxaliplatin Injection if rhabdomyolysis occurs.
  • Based on findings from animal studies and its mechanism of action, Oxaliplatin Injection can cause fetal harm when administered to a pregnant woman. Advise pregnant women of the potential risk to a fetus. Advise males and females of reproductive potential to use an effective method of contraception.
  • Oxaliplatin therapy is associated with a low rate of transient serum aminotransferase elevations, but is commonly associated with sinusoidal and vascular injury to the liver which can lead to sinusoidal obstruction syndrome and to nodular regenerative hyperplasia with noncirrhotic portal hypertension.


What to do in case of emergency/overdose?[edit | edit source]

Symptoms of overdosage may include:


Management of overdosage:

  • Patients suspected of receiving an overdose should be monitored, and supportive treatment should be administered.


Can this medicine be used in pregnancy?[edit | edit source]

  • Oxaliplatin Injection can cause fetal harm when administered to a pregnant woman.
  • Advise a pregnant woman of the potential hazard to a fetus.


Can this medicine be used in children?[edit | edit source]

  • The effectiveness of Oxaliplatin Injection in children has not been established.


What are the active and inactive ingredients in this medicine?[edit | edit source]

  • Active ingredient: oxaliplatin
  • Concentrate for solution for infusion inactive ingredients: lactose monohydrate and water for injection.


Who manufactures and distributes this medicine?[edit | edit source]

Manufactured In The Netherlands By:

  • Pharmachemie B.V.
  • Haarlem, The Netherlands

Manufactured For:

  • Teva Pharmaceuticals USA, Inc.
  • North Wales, PA


What should I know about storage and disposal of this medication?[edit | edit source]

  • Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).
  • DO NOT FREEZE.
  • PROTECT FROM LIGHT.
  • Keep in original outer carton.
  • Oxaliplatin Injection is a cytotoxic drug.
  • Follow applicable special handling and disposal procedures.
Oxaliplatin Resources
Wikipedia


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Deepika vegiraju